Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

NOVO NORDISK A/S (NOVO B)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 04/20 04:59:36 pm
284.2 DKK   -1.17%
04/21NOVO NORDISK A/ : You show 'em Marco!
AQ
04/19NOVO NORDISK A/ : - Share repurchase programme
AQ
04/19NOVO NORDISK A/ : Boys & Girls Clubs of Mercer County’s Garden..
AQ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Novo Nordisk A/S
Develops, manufactures, markets and distributes pharmaceutical products

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products.

It operates through the following business segments: Diabetes & Obesity Care, and Biopharmaceuticals.

The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity.

The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy.

The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Number of employees : 42 076 persons.
Sales per Businesses
20162017Delta
DKK (in Million)%DKK (in Million)%
Diabetes Care and Obesity88,94979.6%92,87783.2% +4.42%
Biopharmaceuticals22,83120.4%18,81916.8% -17.57%
Sales per Regions
20162017Delta
DKK (in Million)%DKK (in Million)%
United States57,19451.2%55,83150% -2.38%
Europe20,68218.5%21,18919% +2.45%
International14,05012.6%---
China10,4589.4%10,7099.6% +2.4%
Pacific9,3968.4%---
Africa, Asia, Middle East & Oceania--12,01810.8%-
Japan & Korea--6,0725.4%-
Latin America--3,6993.3%-
Canada--2,1781.9%-
Managers
NameAgeSinceTitle
Lars Fruergaard Jørgensen, MBA521991President & Chief Executive Officer
Helge Lund, MBA552017Chairman
Maziar Mike Doustdar481992Executive Vice President-International Operations
Karsten Munk Knudsen46-Chief Financial Officer
Mads Krogsgaard Thomsen, PhD581991Chief Science Officer & Executive Vice President
Anne Marie Handrup Kverneland621981Director
Stig Strøbæk541992Director
Elizabeth Anne Hewitt622012Independent Director
Søren Thuesen Pedersen, MBA541994Director
Jeppe Fonager Christiansen592013Vice Chairman
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,962,564,000 1,742,750,000 88.8% 56,000,000 2.9% 69.7%
Share B 10 537,436,000 0 0.0% 0 0.0%
Shareholders
NameEquities%
Novo Nordisk Fonden 160,726,590 8.19%
Novo Nordisk A/S 69,907,173 3.56%
The Vanguard Group, Inc. 44,378,323 2.26%
Norges Bank Investment Management 43,113,675 2.20%
Alecta Pension Insurance Mutual 28,698,000 1.46%
BlackRock Fund Advisors 21,359,422 1.09%
Jupiter Asset Management Ltd. 18,688,980 0.95%
Capital Research & Management Co. (World Investors) 18,275,210 0.93%
Flossbach von Storch AG 18,015,843 0.92%
Fundsmith LLP 13,295,158 0.68%
Holdings
NameEquities%Valuation
Novo Nordisk A/S (NOVO B) 69,907,1733.56%3,448,127,966 USD
Nnit A/S (NNIT) 4,375,00017.5%125,487,031 USD
Innate Pharma (IPH) 8,908,45615.5%62,833,033 USD
Affimed NV (AFMD) 2,663,8304.27%4,928,086 USD
Pieris Pharmaceuticals Inc (PIRS) 0
Company contact information
Novo Nordisk A/S
Novo Allé
Bagsværd, Capital Region 2880

Phone : +45.44.44.88.88
Web : www.novonordisk.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
NOVO NORDISK A/S-15.04%92 039
JOHNSON & JOHNSON-8.71%339 783
PFIZER0.86%217 897
NOVARTIS-7.67%204 972
ROCHE HOLDING LTD.-12.52%191 890
MERCK AND COMPANY4.55%158 571
AMGEN-0.56%114 648
ABBOTT LABORATORIES4.92%103 366
SANOFI-9.14%100 746
BAYER-4.81%100 586
GLAXOSMITHKLINE8.13%99 256
ASTRAZENECA-2.83%88 255
ELI LILLY AND COMPANY-5.58%86 389
BRISTOL-MYERS SQUIBB COMPANY-15.78%83 664
CELGENE CORPORATION-14.12%66 906
ALLERGAN PLC-3.05%54 802
SHIRE-2.01%49 100
JIANGSU HENGRUI MEDICINE CO LTD21.82%37 816
TAKEDA PHARMACEUTICAL CO LTD-25.28%35 853
SAMSUNG BIOLOGICS CO LTD--.--%31 303
ASTELLAS PHARMA INC9.10%30 402
Connections : Novo Nordisk A/S
Fondsmæglerselskabet Maj Invest A/S
Tjaldur P/F
Hofor Forsyning Komplementar A/S
Schlumberger AG
International Crisis Group
Novo Holding A/S
Harno Invest A/S
Haldor Topsoe A/S
Steno Diabetes Center A/S
P/f Tjaldur
University of Copenhagen
HOFOR Forsyning Holding P/S
Novo Nordisk Fonden
Hofor Forsyning A/S
NNE Pharmaplan A/S
Fondsmæglerselskabet Maj Invest A/S (Broker)
Melrose Holdings Ltd.
Maj Invest Holding A/S
Novo Holdings A/S
Silverwood Property Ltd.
SC Triton Industry SRL
© 2018 People , Fundamentals and Ownership